Table 2 Comparison of the demographic among the groups and comparison of duration of BD and current medical therapy between active and inactive BD groups
Active BD group (32 patients) | Inactive BD group (28 patients) | Control group (60 individuals) | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|
Age (mean ± SD) (years) | 43.3 ± 9.9 | 41.9 ± 9.7 | 41.5 ± 9.4 | 0.583 | 0.393 | 0.854 |
Male sex (n, %) | 25, 78.1% | 23, 82.1% | 49, 81.6% | 0.698 | 0.684 | 0.956 |
Disease duration (years) (median [IQR]) | 9.0 [7.0] | 9.0 [9.0] | 0.960 | |||
Current medical therapy, n (%) | ||||||
Colchicine | 21, 65.6% | 17, 60.7% | 0.694 | |||
Azathioprine | 10, 31.3% | 7, 25.0% | 0.592 | |||
Cyclophosphamide | 3, 9.4% | 1, 3.6% | 0.369 | |||
Corticosteroids | 11, 34.4% | 6, 21.4% | 0.267 | |||
Biological | 3, 9.4% | 1, 3.6% | 0.369 | |||